IV Diluent and Saline Vial Seals and Closures

An IV diluent vial seal closes a high-volume, low-value product such as sterile water for injection, sodium chloride injection or dextrose injection, so it is selected on terminal-sterilisation survivability, line throughput and defect rate rather than on any exotic barrier property. The molecule inside is simple; the economics and the process are what make the closure decision hard. Diluents also travel with the fast-access stock they reconstitute, covered on emergency drug vial seals.

This page is for diluent and small-volume-parenteral manufacturers, packaging engineers and procurement teams. It covers what a diluent presentation is, the terminal sterilisation cycle the sealed vial has to survive, the economics of a commodity fill, multi-dose reseal in bacteriostatic presentations, and the Autofits closures that fit.

Key takeaways

IV diluents are sterile water for injection, sodium chloride injection, dextrose injection and bacteriostatic variants, filled in vials from a few millilitres up to around 100 mL.
Most diluents are terminally sterilised by moist heat, so the closure has to survive the cycle with the crimp intact and the disc undistorted, then hold integrity through the cooling phase.
Unit economics dominate. The product is cheap, so the closure’s contribution to cost of goods and to line rejects is disproportionately visible.
Defect rate and dimensional consistency drive capping-line throughput; Autofits works to a critical AQL of nil, major not more than 2.5% and minor not more than 4%, tailorable by agreement.
Bacteriostatic diluents are multi-dose, so the stopper’s self-sealing behaviour and the residual seal force from the crimp both matter across repeated punctures.
Autofits covers the whole diluent size range: 13, 20, 28, 32 and 34 mm.

What an IV diluent presentation is

An IV diluent is a sterile vehicle used to reconstitute a lyophilised drug or to dilute a concentrate before infusion, and the common ones are water for injection, 0.9% sodium chloride injection and 5% dextrose injection. Bacteriostatic water for injection and bacteriostatic sodium chloride injection add a preservative so the vial can be entered more than once. Fill volumes in vials run from around 2 mL for a single reconstitution up to about 100 mL for larger dilution work, with anything above that generally moving to a bag or a bottle.

Two things follow. The diluent vial is usually the partner of another presentation rather than a product in its own right: it sits in a kit or on a shelf beside the lyophilised drug vial it will reconstitute, which makes visual differentiation between the two a real requirement. And batch sizes are very large, so any closure behaviour that costs a fraction of a percent in rejects is a material number.

The container-closure system itself is conventional: a Type I glass vial, an elastomeric stopper and an aluminium or aluminium-plastic seal crimped under the neck flange, as described on the container closure system page. What makes the decision hard is the process, not the parts.

Terminal sterilisation and what it asks of the closure

Simple aqueous diluents are thermally stable, so they are almost always terminally sterilised by moist heat with the closure already crimped in place, which means the closure goes through the autoclave cycle as part of the sealed unit. EU GMP Annex 1 sets the expectation that terminal sterilisation is used where the product and the container permit it, and steam sterilisation by direct contact is described in the USP general chapters on sterilisation of compendial articles published by USP. A 121 °C reference cycle is the usual starting point.

Three effects on the closure are worth designing for. Heat and pressure act on a crimp formed cold, so the residual seal force after the cycle is not necessarily the force applied at capping. The polypropylene disc is exposed to cycle temperature under pressure; polypropylene’s melting range sits well above 121 °C, but softening and dimensional behaviour under load are cycle-specific, so check disc geometry and opening action on product that has been through your actual cycle rather than on unprocessed samples. And the cooling phase pulls the headspace towards partial vacuum, which is precisely the condition a vacuum-decay integrity test exploits, so a closure that is marginal will declare itself here rather than later.

The practical consequence is a sequencing one. A terminally sterilised diluent normally takes the closure in Regular or Ready-to-Sterilize form and sterilises it with the filled vial, rather than buying a pre-sterilised Ready-to-Use closure that would then be autoclaved anyway. Where a diluent is aseptically filled instead, the Ready-to-Use form applies and the guidance on the sterile vial sealing page is the relevant one. Either way the cycle has to be qualified with the actual container-closure system fitted, following the framework on the sterilisation validation page, and integrity confirmed against USP <1207>.

The economics of a commodity fill

Because the product is inexpensive, the closure is a larger share of the finished cost than it is anywhere else in injectables, and a defect that stops the capping line costs more than the closure itself. That reframes the specification conversation. Barrier exotica is not the question; consistency, defect rate and pack format are.

Dimensional consistency is the lever with the biggest effect on throughput. If the inner aluminium diameter, skirt height and thickness vary across a lot, the capping station sees a moving target and either the crimp quality drifts or the reject rate climbs. The mechanism is set out on the seal design and filling speed page. Autofits controls this with in-house polypropylene disc moulding, fully automated washing and 100% high-speed camera inspection, and works to an AQL of nil for critical defects, not more than 2.5% for major and not more than 4% for minor, tailorable by agreement.

Pack format matters more than it sounds. Standard packing is 15,000 per box at 13 mm, 6,000 at 20 mm, 3,000 at 28 mm and 1,400 at 32 mm, in a 420 by 270 by 320 mm box, with Tyvek bagging available. Box changes are handling events on a continuous line, so the count per box feeds into how often an operator interrupts the run. Autofits manufactures around 2.4 billion seals a year from a 75,000 sq ft plant in Nashik, Maharashtra, which is the supply base a continuous diluent programme needs.

Multi-dose bacteriostatic diluents

Bacteriostatic water and bacteriostatic saline are entered repeatedly, so the closure’s job extends past the first puncture to the reseal behaviour of the stopper across the in-use period. The self-sealing and fragmentation properties of the elastomeric closure are the functional tests that speak to this, and they are set out in USP <382> alongside the material requirements in USP <381>.

The aluminium seal contributes indirectly but decisively. It is the crimp that keeps the stopper compressed against the glass sealing surface, and it is the residual seal force from that crimp that determines whether the stopper closes cleanly around each needle track. A flip-off design suits multi-dose diluents because the aluminium skirt stays crimped for the life of the vial while the plastic button exposes a single central injection point, which also keeps the puncture area consistent from dose to dose. The wider single-dose versus multi-dose trade-off is covered on the single versus multi-dose vial page.

Throughput on a diluent line is set as much by the capping station as by the filler, and vial sealing machine types covers the manual, semi-automatic and fully automatic options and the seal tolerances each one needs. Diluent programmes usually span more than one neck at a time, so the 20 mm, 28 mm and 32 mm size pages are the practical index. Where the diluent reconstitutes a freeze-dried product, the closure decision on the drug side is covered on lyophilised vial seals, and the repeated-access case runs through to anaesthetic vials, which are opened the same way under more time pressure.

Which Autofits seals fit IV diluent vials

FlipTop® Optima flip-off, 13 mm and 20 mm: the workhorses for small reconstitution diluents and standard saline vials. The 13 mm has an inner aluminium diameter of 13.36 mm minimum, six taper bridges and a maximum opening force of 30 N; the 20 mm has an inner aluminium diameter of 20.22 mm minimum, six taper bridges and 35 N.
FlipTop® Optima flip-off, 28, 32 and 34 mm: for larger diluent and dilution-vehicle presentations. The 28 mm has eight bridges and a maximum opening force of 35 N; the 32 mm has twelve taper bridges and 65 N; the 34 mm has eight taper bridges.
Tear-off seals in all-aluminium, 13, 20 and 32 mm: the simplest and lowest-component-count option where no plastic button is required and the whole top is removed. The 20 mm version has an inner aluminium diameter of 20.00 to 20.60 mm, a perforation diameter of 9.70 to 10.50 mm and a total height of 7.40 to 8.00 mm.

Colour differentiation is worth using deliberately here. Because a diluent vial commonly sits beside the drug vial it reconstitutes, giving the two closures visibly different disc colours reduces selection error at the point of use; the disc is available in a wide range of colours, matte or glossy, customised to requirement, and options are shown on the colour range page. Seals are supplied Regular, Ready-to-Use (gamma or ethylene-oxide sterilised) or Ready-to-Sterilize, with a 3.5-year shelf life before capping on non-irradiated stock.

Frequently asked questions

What is an IV diluent vial seal?

An IV diluent vial seal is the aluminium or aluminium-plastic closure crimped over the stopper of a sterile diluent vial such as water for injection, sodium chloride injection or dextrose injection. Because the product itself is simple and inexpensive, the seal is specified around surviving terminal sterilisation, holding container closure integrity, and running cleanly at high line speeds with a low defect rate.

Can a flip-off seal go through an autoclave?

Aluminium is unaffected at steam-sterilisation temperatures and polypropylene’s melting range sits well above a 121 °C cycle, so the construction is compatible in principle. What has to be established for your product is cycle-specific: whether the residual seal force after the cycle stays in the qualified range, whether the disc geometry and opening action are unchanged, and whether integrity holds through the cooling phase. Qualify the cycle with the actual container-closure system fitted rather than relying on the closure specification alone.

Which seal form should I buy for a terminally sterilised diluent?

Normally Regular or Ready-to-Sterilize, because the closure is crimped onto the vial before the sterilisation cycle and is sterilised as part of the sealed unit. A pre-sterilised Ready-to-Use closure adds cost that the autoclave step then makes redundant. Ready-to-Use is the right form for aseptically filled diluents, where the seal enters a clean area double-bagged and already gamma or ethylene-oxide sterilised.

What size seals do diluent vials use?

Diluent vials span the range. Small reconstitution volumes use 13 mm, standard saline and water for injection vials use 20 mm, and larger dilution presentations move to 28, 32 and 34 mm. Autofits makes the FlipTop Optima flip-off seal in all five sizes, so a full diluent portfolio can be sealed against one specification family.

How do seals affect throughput on a high-volume diluent line?

Through dimensional consistency and defect rate. If the inner aluminium diameter, skirt height and thickness drift across a lot, the capping station either produces variable crimps or rejects more units, and at diluent volumes a fraction of a percent is a large number. Consistent geometry, 100% camera inspection and a tight AQL are what keep a continuous line running; pack count per box also affects how often the run is interrupted for a box change.

Do bacteriostatic multi-dose diluents need a different closure?

The aluminium seal is the same family, but the stopper specification carries more weight because the vial is entered repeatedly. Self-sealing and fragmentation are the functional properties that matter, tested under USP <382>, with material requirements under USP <381>. The seal’s contribution is the crimp: it holds the stopper compressed against the glass so the elastomer closes cleanly around each needle track for the in-use period.

Sources

Autofits FlipTop Seals dossier and engineering drawings (working/spec-sheets/)
EudraLex Volume 4, EU GMP Annex 1, Manufacture of Sterile Medicinal Products (https://health.ec.europa.eu/)
USP-NF: General Chapters on Sterilization of Compendial Articles and Steam Sterilization by Direct Contact (https://www.usp.org/)
USP-NF: General Chapter <381>, Elastomeric Closures for Injections (https://www.usp.org/)
USP-NF: General Chapter <382>, Elastomeric Component Functional Suitability in Parenteral Product Packaging (https://www.usp.org/)
USP-NF: General Chapter <1207>, Package Integrity Evaluation, Sterile Products (https://www.usp.org/)
ISO: ISO 15378:2017, Primary packaging materials for medicinal products, GMP requirements (https://www.iso.org/standard/70729.html)

“`json { “@context”: “https://schema.org”, “@graph”: [ { “@type”: “Article”, “headline”: “IV Diluent and Saline Vial Seals and Closures”, “description”: “How to select a vial seal for IV diluents such as water for injection, saline and dextrose, covering terminal sterilisation duty, high-volume line economics and defect rate, multi-dose bacteriostatic reseal, and the Autofits closures that fit.”, “author”: {“@type”: “Organization”, “name”: “Autofits Technical Team”}, “publisher”: { “@type”: “Organization”, “name”: “Autofits Packaging Pvt. Ltd.”, “address”: { “@type”: “PostalAddress”, “streetAddress”: “E-13/7/4, MIDC, Malegaon, Sinnar”, “addressLocality”: “Nashik”, “addressCountry”: “IN” } }, “datePublished”: “2026-07-31”, “dateModified”: “2026-07-31” }, { “@type”: “ItemList”, “name”: “Autofits closures for IV diluent and saline vials”, “itemListElement”: [ {“@type”: “ListItem”, “position”: 1, “name”: “FlipTop Optima flip-off seal, 13 mm”, “url”: “/products/fliptop-seals/optima/13mm/”}, {“@type”: “ListItem”, “position”: 2, “name”: “FlipTop Optima flip-off seal, 20 mm”, “url”: “/products/fliptop-seals/optima/20mm/”}, {“@type”: “ListItem”, “position”: 3, “name”: “FlipTop Optima flip-off seal, 28 mm”, “url”: “/products/fliptop-seals/optima/28mm/”}, {“@type”: “ListItem”, “position”: 4, “name”: “Tear-off aluminium seals”, “url”: “/tear-off/”} ] }, { “@type”: “FAQPage”, “mainEntity”: [ {“@type”: “Question”, “name”: “What is an IV diluent vial seal?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “An IV diluent vial seal is the aluminium or aluminium-plastic closure crimped over the stopper of a sterile diluent vial such as water for injection, sodium chloride injection or dextrose injection. Because the product itself is simple and inexpensive, the seal is specified around surviving terminal sterilisation, holding container closure integrity, and running cleanly at high line speeds with a low defect rate.”}}, {“@type”: “Question”, “name”: “Can a flip-off seal go through an autoclave?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Aluminium is unaffected at steam-sterilisation temperatures and polypropylene’s melting range sits well above a 121 degree Celsius cycle, so the construction is compatible in principle. What has to be established for your product is cycle-specific: whether the residual seal force after the cycle stays in the qualified range, whether the disc geometry and opening action are unchanged, and whether integrity holds through the cooling phase. Qualify the cycle with the actual container-closure system fitted.”}}, {“@type”: “Question”, “name”: “Which seal form should I buy for a terminally sterilised diluent?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Normally Regular or Ready-to-Sterilize, because the closure is crimped onto the vial before the sterilisation cycle and is sterilised as part of the sealed unit. A pre-sterilised Ready-to-Use closure adds cost that the autoclave step then makes redundant. Ready-to-Use is the right form for aseptically filled diluents, where the seal enters a clean area double-bagged and already gamma or ethylene-oxide sterilised.”}}, {“@type”: “Question”, “name”: “What size seals do diluent vials use?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Diluent vials span the range. Small reconstitution volumes use 13 mm, standard saline and water for injection vials use 20 mm, and larger dilution presentations move to 28, 32 and 34 mm. Autofits makes the FlipTop Optima flip-off seal in all five sizes, so a full diluent portfolio can be sealed against one specification family.”}}, {“@type”: “Question”, “name”: “How do seals affect throughput on a high-volume diluent line?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Through dimensional consistency and defect rate. If the inner aluminium diameter, skirt height and thickness drift across a lot, the capping station either produces variable crimps or rejects more units, and at diluent volumes a fraction of a percent is a large number. Consistent geometry, 100% camera inspection and a tight AQL are what keep a continuous line running; pack count per box also affects how often the run is interrupted for a box change.”}}, {“@type”: “Question”, “name”: “Do bacteriostatic multi-dose diluents need a different closure?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “The aluminium seal is the same family, but the stopper specification carries more weight because the vial is entered repeatedly. Self-sealing and fragmentation are the functional properties that matter, tested under USP <382>, with material requirements under USP <381>. The seal’s contribution is the crimp: it holds the stopper compressed against the glass so the elastomer closes cleanly around each needle track for the in-use period.”}} ] }, { “@type”: “BreadcrumbList”, “itemListElement”: [ {“@type”: “ListItem”, “position”: 1, “name”: “Home”, “item”: “/”}, {“@type”: “ListItem”, “position”: 2, “name”: “Applications”, “item”: “/applications/”}, {“@type”: “ListItem”, “position”: 3, “name”: “IV Diluents”, “item”: “/applications/iv-diluents/”} ] } ] } “`

*Last updated: 2026-07-31. This page is general technical information, not regulatory or compliance advice; confirm current standard editions, your sterilisation cycle and your own specification with Autofits and the issuing bodies.*